Search

everythinglearnresearchcommunity

for

Search:↓

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

The review says skin conditions with sterile pustules need more research for better treatments.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

Immunoadsorption successfully treated a man's resistant polymyositis.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Hairless HRS/J mice resist Bacillus anthracis skin infections due to high numbers of immune cells, not because they lack hair follicles.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.